MRD / Regn No. : 20250000735 Date : 23/06/2026
Patient Name : Mrigen Uzir Age & Gender : 63 Yrs. / Male
Contact No. : 9435340376 UHID :
Ht / Wt / BMI : BP S / BP D :
Allergies : NKA Referred By :
   
Problem List : TYPE 2 DM (17/Sep/2008) |
Subjective : TYPE 2 DM,HAS STOPPED OZEMPIC
Objective : NONE
Analysis : TYPE 2 DM,INCREASED FIB4 / NAFLD SCORE,S3F1 MASLD,MILD TSH ELEVATION,A1G2 DKD
Plan : INCREASED SEMAGLUTIDE 1 MG,SEE ME IN 6 WEEKS  
Salient Investigations : FASTING PLASMA GLUCOSE (FPG): 152 mg/dL | POST PRANDIAL GLUCOSE (2HPP): 228 mg/dL
S# Generic (Trade) Name Route Dosage Usage Duration
1 TABLET DAPAGLIFLOZIN 10 MG PIOGLITAZONE 15 MG
GLUXIT PRO
Medicine For DIABETES NAFLD 		PO 1-0-0 BEFORE FOOD
 TILL NEXT VISIT
MAY CAUSE GENTIOURINARY INFECTION AND EDEMA
2 INJECTION DEGLUDEC (INJ U100)
TRESIBA
Medicine For DIABETES 		SQ 0-0-6 UNITS AT BEDTIME
 TILL NEXT VISIT
MAY CAUSE HYPOGLYCEMIA
3 INJECTION SEMAGLUTIDE 1 MG
OZEMPIC
Medicine For OBESITY DIABETES 		SQ ONCE A WEEK AS DIRECTED NO RELATION TO FOOD
 TILL NEXT VISIT
MAY CAUSE NAUSEA VOMITING
       
Refill : 0 / Substitution:    
Education :
Next Visit : 07/Aug/2026
Tests Suggested For Next Visit : FBS 2HPP
   
   

Dr. Krishna G Seshadri
Sr. Consultant Endocrinology Diabetes and Metabolism
Tamil Nadu / 48748 HPRID: 71-0638-2075-7542

Disclaimer: This is an ONLINE consultation. The patient has not been physically examined. The prescription or advice is based on the patient's description of the problem which is given above and also explained over video consultation.
This is a Computer generated Prescription

Powered By: